enGene Holdings Statistics

Total Valuation

enGene Holdings has a market cap or net worth of $539.66 million. The enterprise value is $369.12 million.

Market Cap	539.66M
Enterprise Value	369.12M

Important Dates

The next estimated earnings date is Friday, December 19, 2025, after market close.

Earnings Date	Dec 19, 2025
Ex-Dividend Date	n/a

Share Statistics

enGene Holdings has 66.87 million shares outstanding. The number of shares has increased by 83.91% in one year.

Current Share Class	66.87M
Shares Outstanding	66.87M
Shares Change (YoY)	+83.91%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	0.67%
Owned by Institutions (%)	32.22%
Float	32.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.06
P/TBV Ratio	2.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.34, with a Debt / Equity ratio of 0.16.

Current Ratio	10.34
Quick Ratio	9.91
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.71

Financial Efficiency

Return on equity (ROE) is -43.95% and return on invested capital (ROIC) is -25.95%.

Return on Equity (ROE)	-43.95%
Return on Assets (ROA)	-24.67%
Return on Invested Capital (ROIC)	-25.95%
Return on Capital Employed (ROCE)	-44.93%
Revenue Per Employee	n/a
Profits Per Employee	-$1.66M
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, enGene Holdings has paid $516,000 in taxes.

Income Tax	516,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.83% in the last 52 weeks. The beta is -0.27, so enGene Holdings's price volatility has been lower than the market average.

Beta (5Y)	-0.27
52-Week Price Change	-5.83%
50-Day Moving Average	7.70
200-Day Moving Average	5.17
Relative Strength Index (RSI)	54.89
Average Volume (20 Days)	3,269,711

Short Selling Information

The latest short interest is 1.19 million, so 1.78% of the outstanding shares have been sold short.

Short Interest	1.19M
Short Previous Month	29,230
Short % of Shares Out	1.78%
Short % of Float	3.63%
Short Ratio (days to cover)	0.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-101.14M
Pretax Income	-94.21M
Net Income	-94.72M
EBITDA	-100.95M
EBIT	-101.14M
Earnings Per Share (EPS)	-$1.92

Full Income Statement

Balance Sheet

The company has $201.91 million in cash and $31.38 million in debt, giving a net cash position of $170.54 million or $2.55 per share.

Cash & Cash Equivalents	201.91M
Total Debt	31.38M
Net Cash	170.54M
Net Cash Per Share	$2.55
Equity (Book Value)	200.67M
Book Value Per Share	3.93
Working Capital	190.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$93.85 million and capital expenditures -$1.29 million, giving a free cash flow of -$95.13 million.

Operating Cash Flow	-93.85M
Capital Expenditures	-1.29M
Free Cash Flow	-95.13M
FCF Per Share	-$1.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

enGene Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-83.91%
Shareholder Yield	-83.91%
Earnings Yield	-17.55%
FCF Yield	-17.63%

Analyst Forecast

The average price target for enGene Holdings is $22.71, which is 181.41% higher than the current price. The consensus rating is "Buy".

Price Target	$22.71
Price Target Difference	181.41%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2